Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000252628 | SCV000313404 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001610709 | SCV001838320 | benign | not provided | 2018-07-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002374426 | SCV002688079 | benign | Cardiovascular phenotype | 2018-12-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000252628 | SCV001977696 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000252628 | SCV001977796 | benign | not specified | no assertion criteria provided | clinical testing |